There are two H1N1 vaccines—adjuvanted and non-adjuvanted. The adjuvanted vaccine is for the general public and the unadjuvanted vaccine is for pregnant women. Adjuvanted vaccine contains an additive, called an adjuvant, which is an ingredient made of naturally occurring oil, water and vitamin E that boosts the body’s immune response and makes the vaccine work better for most people. Adjuvants are also used in other vaccines. The unadjuvanted vaccine does not contain an additive.
We encourage all Nova Scotians to get vaccinated. Nova Scotia has ordered enough vaccine for every Nova Scotian who wants it.
The vaccine is strongly recommended for anyone at high risk of influenza-related complications and for those who care for them. This includes:
The H1N1 flu vaccine is not approved for children under six months. As well, the following groups of people should not receive the vaccine:
Yes. Both types of the H1N1 vaccine can be given at the same time as the seasonal flu vaccine.
Common side effects include:
As with any vaccine, more serious reactions may occur, but are rare. People should stay in the clinic for 15 minutes after immunization to be monitored for any allergic reaction.
Getting vaccinated is the best way to protect yourself, and those around you, from getting sick with H1N1. The benefit of immunization—the prevention of serious illness and death—far outweighs any risk associated with being immunized.
The vaccine gives some immunity to the current strain of the H1N1 flu virus within 10 days.
Major research into the safety of any vaccine is done before it is used. Canada has very strict requirements for vaccines approved for use in Canada. Vaccines are safety-tested by the manufacturer and by Health Canada. Health Canada reviews all available test results, including international data, to ensure the vaccine is safe and effective before it is given to Canadians.
Using an additive (adjuvant) in a vaccine is not new. Adjuvants are used in many other vaccines in Canada. The adjuvant used in the H1N1 vaccine, although new in Canada, has already been widely used in Europe in other vaccines and has been evaluated by Health Canada. No safety concerns have been found.
Both the adjuvanted and unadjuvanted H1N1 vaccines have been tested and reviewed before being approved for use.